FIND ANNOUNCES NEW WAVE OF ACTIVITIES TO ADDRESS HCV ELIMINATION
The Foundation for Innovative New Diagnostics (FIND) announced last Friday that it has awarded grants to a number of companies to address the urgent diagnostic needs for hepatitis C virus (HCV). These grants will be used to conduct feasibility studies of various technologies that could transform HCV testing at the point of care. Mologic is among the companies receiving support to develop and validate prototype HCV core antigen (cAg) tests on their innovative rapid diagnostic test platform. Read more on the official website: https://www.finddx.org/news/find-announces-new-wave-activities-addressing-challenges-threatening-hepc-elimination/
in the last month
Hours in the lab
so far this year
EXPLORE WHAT WE CAN DO AT MOLOGIC
Take a look at our expertise. And if you can't see exactly what you're after, contact us. We'll be delighted to discuss your project with you.